查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1319089

肿瘤 NGS 市场：按技术、产品和服务、用途- 2023-2030 年全球预测

Oncology NGS Market by Technology, Product & Service, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2023 年，全球肿瘤 NGS 市场将大幅成长，达到 4.3826 亿美元，年复合成长率为 15.41%，预计到 2030 年将达到惊人的 123.9 万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球肿瘤NGS市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 肿瘤NGS的全球市场规模与预测为何？

2. 在预测期内，COVID-19 对全球肿瘤 NGS 市场的阻碍因素和影响有哪些？

3. 在预测期内，全球肿瘤NGS市场需要投资哪些产品/细分市场/应用/领域？

4. 你们在全球肿瘤NGS市场的竞争策略是什么？

5. 全球肿瘤NGS市场的技术趋势和法律规范是什么？

6. 全球肿瘤NGS市场主要厂商的市占率是多少？

7. 哪些型态和策略措施被认为适合肿瘤NGS进入全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症罹患率上升所带来的潜在需求
      • 个人化医疗在临床肿瘤学中日益普及
      • 基因序列测定方案成本降低，消费者采用率提高
    • 抑制因素
      • 资料管理缺乏计算效率
    • 机会
      • 增加政府对肿瘤研究和领域的配合措施和投资
      • 全球全基因组序列测定新进展
    • 任务
      • 报销政策有限且不充分
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章肿瘤学 NGS 市场：依技术分类

  • 扩增子碱基
  • 杂交基地
  • 标靶和基因组定序
  • 全外显子定序
  • 全基因组序列测定

第7章肿瘤学 NGS 市场（按产品和服务）

  • 平台及相关产品
    • 消耗品
    • 控制板
    • 平台
  • 服务
    • 按工作流程
    • NGS资料分析
    • NGS预测序
    • NGS原始资料分析
    • NGS二次资料分析
    • NGS定序
    • NGS三级资料分析

第8章肿瘤学 NGS 市场：依用途

  • 学术和临床研究
  • 医院和诊所
  • 製药和生物技术公司

第9章美洲肿瘤NGS市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太肿瘤NGS市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲肿瘤NGS市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-3A2E844FECCB

The Global Oncology NGS Market is forecasted to grow significantly, with a projected USD 438.26 million in 2023 at a CAGR of 15.41% and expected to reach a staggering USD 1,200.39 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Oncology NGS Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Oncology NGS Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Technology, market is studied across Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing. The Amplicon-based is projected to witness significant market share during forecast period.

Based on Product & Service, market is studied across Platforms & Related Products and Services. The Platforms & Related Products is further studied across Consumables, Panels, and Platforms. The Services is further studied across By Workflow, NGS Data Analysis, NGS Pre-Sequencing, NGS Primary Data Analysis, NGS Secondary Data Analysis, NGS Sequencing, and NGS Tertiary Data Analysis. The Services is projected to witness significant market share during forecast period.

Based on Application, market is studied across Academic & Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Oncology NGS Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oncology NGS Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oncology NGS Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oncology NGS Market?

4. What is the competitive strategic window for opportunities in the Global Oncology NGS Market?

5. What are the technology trends and regulatory frameworks in the Global Oncology NGS Market?

6. What is the market share of the leading vendors in the Global Oncology NGS Market?

7. What modes and strategic moves are considered suitable for entering the Global Oncology NGS Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Oncology NGS Market, by Technology, 2022 vs 2030
  • 4.3. Oncology NGS Market, by Product & Service, 2022 vs 2030
  • 4.4. Oncology NGS Market, by Application, 2022 vs 2030
  • 4.5. Oncology NGS Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand attributed to rising prevalence of cancer incidence globally
      • 5.1.1.2. Growing popularity of personalized medicine in clinical oncology
      • 5.1.1.3. Increasing consumer adoption owing to decreasing costs for genetic sequencing solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of computational efficiency for data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising governmental initiatives and investments in the field of research and development in oncology
      • 5.1.3.2. Emerging advancements for whole-genome sequencing worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Limited and inadequate reimbursement policies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Oncology NGS Market, by Technology

  • 6.1. Introduction
  • 6.2. Amplicon-based
  • 6.3. Hybridization-based
  • 6.4. Targeted & Gene Panel Sequencing
  • 6.5. Whole Exome Sequencing
  • 6.6. Whole Genome Sequencing

7. Oncology NGS Market, by Product & Service

  • 7.1. Introduction
  • 7.2. Platforms & Related Products
    • 7.2.1. Consumables
    • 7.2.2. Panels
    • 7.2.3. Platforms
  • 7.3. Services
    • 7.3.1. By Workflow
    • 7.3.2. NGS Data Analysis
    • 7.3.3. NGS Pre-Sequencing
    • 7.3.4. NGS Primary Data Analysis
    • 7.3.5. NGS Secondary Data Analysis
    • 7.3.6. NGS Sequencing
    • 7.3.7. NGS Tertiary Data Analysis

8. Oncology NGS Market, by Application

  • 8.1. Introduction
  • 8.2. Academic & Clinical Research
  • 8.3. Hospitals & Clinics
  • 8.4. Pharma & Biotech Entities

9. Americas Oncology NGS Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oncology NGS Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oncology NGS Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ONCOLOGY NGS MARKET RESEARCH PROCESS
  • FIGURE 2. ONCOLOGY NGS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 5. ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
  • FIGURE 6. ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. ONCOLOGY NGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. ONCOLOGY NGS MARKET DYNAMICS
  • FIGURE 9. ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ONCOLOGY NGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 5. ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 11. ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 12. ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ONCOLOGY NGS MARKET SIZE, BY PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 17. ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 239. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 240. ONCOLOGY NGS MARKET LICENSE & PRICING